While the coronavirus has impacted millions of Americans across the United States, it has hit the elderly population particularly hard. In fact, more than 40 percent of coronavirus deaths in the U.S. have been linked to long-term care facilities, according to a New York Times survey. In an effort to bring those numbers down, pharmaceutical company Eli Lilly, in partnership with the National Institutes of Health (NIH), has just launched a late-stage antibody treatment trial focusing on residents and staff at nursing homes.
"COVID-19 has had a devastating impact on nursing home residents," Lilly's chief scientific officer Daniel Skovronsky said in a statement. "We're working as fast as we can to create medicines that might stop the spread of the virus to these vulnerable individuals."
The trial is expected to enroll up to 2,400 participants who live or work at a facility and have recently been diagnosed with the disease. The trial will evaluate the safety and success of using LY-CoV555, a potent, neutralizing antibody that works against the spike protein of the novel coronavirus. The trial will look at whether a single dose of the antibody treatment reduces the rate of infection over four weeks as well as symptoms over eight weeks.
"The importance of these kinds of therapies for people like the elderly or immunocompromised is that they can provide the hope and the safety net that these people really need right now," said Andrew Adams, vice president of new therapeutic modalities & COVID-19 research at Eli Lilly, who is overseeing the trial. "I think people in those populations are really desperate and looking for something to help with the coronavirus."
Eli Lilly is taking its trial on the road with customized mobile research units that can travel directly to areas that are experiencing outbreaks.
"This is an interesting solution, to bring the medicine to these vulnerable patients," said Adams. "This lets us be flexible and move these trials around the country, tracking these trials as we come across them."
Adams said he is hoping Eli Lilly will have results on the efficacy of these antibodies in the fourth quarter of this year. Even if successful, though, he says research for a vaccine needs to continue.
"These have to be thought of as more of a bridge, where a vaccine provides long-term protection in terms of years of immunity, where we will provide hopefully in the range of months with these types of treatments. We hope this to be a short-term bridge to the long-term effective vaccination," he said.
Carlo and Baker cover the big races to watch on this off-cycle Election Day, the concrete pledges starting to come out of COP26, Jeffrey Epstein keeps causing CEOs to lose their jobs, and Ryan Murphy's TV hit that wasn't.
The UN climate change conference kicked off on Sunday with about 120 world leaders and delegates gathering in Glasgow, Scotland this week, as experts continue to warn about the harms of heightened emissions and the effects on climate change. The topic of ESG investing is expected to be a top priority at the summit. Jefferies global head of ESG and sustainability research Aniket Shah joined Cheddar News' Closing Bell to discuss.
Christian Kroll, CEO of Ecosia, joins 'Fast Forward' to discuss how Ecosia uses its ad revenue to plant trees, and what the company plans to do after launching a $405 million venture capital fund focused on combating the climate crisis.
Dr. Ashley McClure, co-founder of Climate Health Now, joins 'Fast Forward' to discuss why the climate crisis is the greatest threat to humanity and health, and measures we need to take to reverse course.
Clinical research company Medable has secured $304 million in Series D funding, marking its fourth round since 2020, giving the firm a valuation of just over $2 billion. Dr. Michelle Longmire, CEO and Co-founder, Medable joined Cheddar's Opening Bell to discuss the future of the company.
The National Hurricane Center announced that the list of storm names in 2021 has been exhausted as one of the most active hurricane seasons in history continues to stir in the Atlantic Ocean. Subtropical Storm Wanda marks only the third time in history (last year being the second) that all the names were used in a single season.
Astronomers at NASA have located what could be the first exoplanet not only outside of the solar system but outside of our own galaxy in the Messier 51 (or the Whirlpool Galaxy), 28 million light-years away. It could take astronomers up to 70 years to see if the planet passes in front of its star to verify the find.
Even with pandemic lockdowns, greenhouse gas levels reached new highs in 2020, according to the World Meteorological Organization. This report comes just a week ahead of the United Nations Climate Change Conference, otherwise known as Cop26. Shannon Osaka, climate policy and solutions reporter at Grist, joined Cheddar's Between Bells to discuss.
Oatly Chief Sustainability Officer, Ashley Allen joins Cheddar News to talk about food waste and hows its been left off the table in the upcoming COP26 agenda. Ashley will be on the ground at COP26 and advocating for this conversation to get the attention it deserves.
Carlo's flying solo today, talking COP26 and climate change, another racially charged trial gets underway, SCOTUS takes on abortion and a stunning rise in traffic deaths points to a bigger societal breakdown sparked by the pandemic.
